Allergy-treating nasal spray needs more research before approval: U.S. FDA
Global News
The ARS product is one of several needle-free devices being developed to treat dangerous reactions to food, insect stings and medications.
Federal regulators declined to approve a nasal spray to treat severe allergic reactions late Tuesday, calling for more research on what would have been the first alternative to injections using devices such as an EpiPen.
The U.S. Food and Drug Administration told ARS Pharmaceuticals Inc., of San Diego, that the company needs to conduct another study on repeat doses of epinephrine, a drug that halts potentially life-threating reactions, called anaphylaxis, using the company’s nasal spray device compared with injections.
The move comes four months after an FDA advisory committee recommended approval of the device, dubbed neffy. The FDA is not required to follow the committee’s recommendations, though it usually does.
Richard Lowenthal, president and chief executive of ARS, said in a statement that the company would appeal the FDA’s decision and resubmit an application in early 2024.
The ARS product is one of several needle-free devices being developed to treat dangerous reactions to food, insect stings and medications. Such a device could alter treatment for the between 33 million and 45 million Americans with severe allergies to food and other triggers.
Advocates for people with allergies said they were “frustrated” by the FDA’s request for more research.
“Our community believe this innovation would finally come to the more than 10% of Americans with life-threatening food allergies, but instead, the FDA will force us to wait even longer,” Sung Poblete, chief executive of Food Allergy Research & Education, a nonprofit group, said in a statement.
The motion won't mean the city is investing or accepting payment in cryptocurrency any time soon, but will instead direct staff to look into those possibilities.
Enbridge officials said in a statement that the reroute proposal has gone through rigorous reviews and studies.
A proposed deal that would see three tobacco giants pay out billions to provinces and territories, as well as smokers across Canada, has been approved by the companies' creditors.
Tokyo recently announced a four-day workweek policy in an effort to boost Japan’s record-low fertility rate - something that Canada is also struggling with.
More than 1,500 firefighters were battling the blaze, many working in steep canyons, according to the California Department of Forestry and Fire Protection, known as Cal Fire.
Evidence has grown in recent years that highly processed foods are linked to a wide range of chronic health problems, like diabetes and heart disease.
Environment and Climate Change Canada has released its list of the top 10 most impactful weather events of 2024.
Fifteen charges under the federal Fisheries Act have been laid against Imperial Metals Corp. more than 10 years after a tailings pond collapsed the Mount Polley mine.
Many kids and teens are looking forward to the holidays with great excitement, but others find it a difficult time of year filled with anxiety, stress and loneliness. It’s something Alisa Simon, the chief youth officer at Kids Help Phone, says they watch for when school pauses for the winter break, noting, “we do see an increase...
Advocates and friends of a Nova Scotia woman who died from stage IV breast cancer are urging the province to update its screening policy for women with dense breast tissue.
The report estimates a cancer patient will face almost $33,000 on average in out-of-pocket cancer-related costs in their lifetime, including loss of income.